A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 4,941 shares of RGEN stock, worth $593,315. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,941
Previous 6,502 24.01%
Holding current value
$593,315
Previous $1.17 Million 22.33%
% of portfolio
0.02%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$170.78 - $208.42 $266,587 - $325,343
-1,561 Reduced 24.01%
4,941 $908,000
Q4 2023

Feb 07, 2024

BUY
$114.17 - $185.35 $359,521 - $583,667
3,149 Added 93.92%
6,502 $1.17 Million
Q3 2023

Nov 08, 2023

BUY
$138.78 - $176.51 $42,189 - $53,659
304 Added 9.97%
3,353 $533,000
Q2 2023

Jul 28, 2023

SELL
$138.42 - $180.31 $292,758 - $381,355
-2,115 Reduced 40.96%
3,049 $431,000
Q1 2023

May 10, 2023

BUY
$154.26 - $198.1 $93,327 - $119,850
605 Added 13.27%
5,164 $869,000
Q4 2022

Feb 10, 2023

SELL
$162.42 - $220.56 $43,690 - $59,330
-269 Reduced 5.57%
4,559 $771,000
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $75,718 - $120,931
472 Added 10.84%
4,828 $903,000
Q2 2022

Aug 09, 2022

SELL
$140.68 - $188.02 $130,691 - $174,670
-929 Reduced 17.58%
4,356 $707,000
Q1 2022

May 16, 2022

BUY
$161.19 - $257.96 $305,293 - $488,576
1,894 Added 55.85%
5,285 $994,000
Q4 2021

Feb 23, 2022

BUY
$247.59 - $304.47 $146,325 - $179,941
591 Added 21.11%
3,391 $898,000
Q3 2021

Nov 09, 2021

BUY
$194.77 - $324.21 $160,685 - $267,473
825 Added 41.77%
2,800 $809,000
Q2 2021

Aug 11, 2021

BUY
$165.87 - $220.95 $136,511 - $181,841
823 Added 71.44%
1,975 $394,000
Q1 2021

Apr 28, 2021

BUY
$180.37 - $226.26 $207,786 - $260,651
1,152 New
1,152 $224,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.66B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.